Iscaff Pharma Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Iscaff Pharma General Information

Description

Developer of a biotechnology platform designed to focus on developing treatments for aggressive cancers. The company's platform provides cost-effective technology to enhance the success of clinical development of treatments for cancer, it provides technology for cancer diagnosis, prognosis, and testing of cancer drugs, enabling doctors to get a possible treatment for cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Erik Dahlbergsgatan 11A
  • 411 26 Gothenburg
  • Sweden
+46 070-215
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Erik Dahlbergsgatan 11A
  • 411 26 Gothenburg
  • Sweden
+46 070-215

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Iscaff Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Dec-2025 Completed Clinical Trials - Phase 2
4. Early Stage VC 01-Jan-2022 Completed Startup
3. Early Stage VC 01-Jan-2021 Completed Startup
2. Early Stage VC 01-Jan-2019 $88.6K $88.6K Completed Startup
1. Accelerator/Incubator 01-Jun-2017 Completed Startup
To view Iscaff Pharma’s complete valuation and funding history, request access »

Iscaff Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 4,000 $21.95 $21.95 1x $21.95 5.6%
To view Iscaff Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Iscaff Pharma Patents

Iscaff Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4351669-A1 Bioink for reproducible production of 3d tumor tissue scaffolds Inactive 10-Jun-2021
US-20250122468-A1 Bioink for reproducible production of 3d tumor tissue scaffolds Pending 10-Jun-2021
WO-2022260583-A1 Bioink for reproducible production of 3d tumor tissue scaffolds Inactive 10-Jun-2021
EP-4103697-A1 Uses of patient-derived scaffolds Inactive 03-Nov-2020
EP-4103697-A4 Uses of patient-derived scaffolds Inactive 03-Nov-2020 C12N5/0693
To view Iscaff Pharma’s complete patent history, request access »

Iscaff Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Iscaff Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Life Science Invest Angel Group Minority
To view Iscaff Pharma’s complete investors history, request access »

Iscaff Pharma FAQs

  • When was Iscaff Pharma founded?

    Iscaff Pharma was founded in 2017.

  • Where is Iscaff Pharma headquartered?

    Iscaff Pharma is headquartered in Gothenburg, Sweden.

  • What is the size of Iscaff Pharma?

    Iscaff Pharma has 6 total employees.

  • What industry is Iscaff Pharma in?

    Iscaff Pharma’s primary industry is Drug Discovery.

  • Is Iscaff Pharma a private or public company?

    Iscaff Pharma is a Private company.

  • What is Iscaff Pharma’s current revenue?

    The current revenue for Iscaff Pharma is .

  • How much funding has Iscaff Pharma raised over time?

    Iscaff Pharma has raised $1.29M.

  • Who are Iscaff Pharma’s investors?

    Life Science Invest has invested in Iscaff Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process